LMAO, so being from another Country is reason for your constant dilution bashing? Sorry, I can apprehend what you're doing just fine. Once again, you just couldn't resist posting again about your made up share dumping. We shall see when the next report is released.
You do realized VDRM is a penny stock in the earliest phase of it's development, right? How would you suggest management rise funds to expedite an aggressive growth plan as Viadrema's.
It takes a lot of money to bring new products to market and if management needs to rise money by selling shares; I'm okay with that, as long as it is done conservatively, responsibly and only as needed until income offsets the cost.
So far management has proven to be both conservative and responsible therefore retaining my trust, investment and support.
Market Data 
Markets 
AI
